Institutions / Nantahala Capital Management, LLC
Nantahala Capital Management, LLC
CIK 1472322 · Institutionalso an insider · as of Dec 31, 2025
Portfolio value
$1.68B
Positions
133
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 133 →
| Company | Value | % of portfolio |
|---|---|---|
| Bancorp Inc/The | $72.36M | 4.3% |
| Establishment Labs Holdings Inc. | $71.98M | 4.3% |
| Hilton Grand Vacations Inc. | $69.88M | 4.2% |
| Soleno Therapeutics, Inc. | $60.84M | 3.6% |
| Xtant Medical Holdings, Inc.XTNT | $53.62M | 3.2% |
| Fulcrum Therapeutics, Inc. | $48.56M | 2.9% |
| Bioventus Inc.BVS | $44.99M | 2.7% |
| Savara IncSVRA | $44.29M | 2.6% |
| Evolus, Inc. | $38.71M | 2.3% |
| Fox Factory Holding Corp | $37.44M | 2.2% |
| Peloton Interactive, Inc. | $36.55M | 2.2% |
| Gogo Inc.GOGO | $31.65M | 1.9% |
| Tango Therapeutics, Inc. | $31.65M | 1.9% |
| Amneal Pharmaceuticals, Inc. | $30.84M | 1.8% |
| Eventbrite, Inc. | $30.50M | 1.8% |
| iShares Tr | $28.84M | 1.7% |
| Abeona Therapeutics Inc. | $26.16M | 1.6% |
| Rapt Therapeutics Inc | $25.54M | 1.5% |
| Fractyl Health, Inc.GUTS | $23.86M | 1.4% |
| Avalo Therapeutics, Inc. | $22.43M | 1.3% |
| Abivax SA | $20.66M | 1.2% |
| Eton Pharmaceuticals, Inc. | $19.89M | 1.2% |
| Globus Medical Inc | $19.64M | 1.2% |
| Adc Therapeutics SA | $19.33M | 1.2% |
| Fossil Group, Inc. | $19.04M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.
Insider transactions
Also files Forms 3 / 4 / 5
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Grant | TLPH Talphera, Inc. Pre-Funded Warrants | — | +4.3M +29.31% | 18,822,267 36.26% of shares | low |